Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.
Advancing professional knowledge and offering credits for attorneys, staff and other professionals.
Helping clients respond correctly when a crisis occurs.
Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.
Leveraging law and technology to deliver sound solutions.
Delivering seamless service through partnerships across the globe.
Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.
Industry-leading conferences focused on affordable housing, tax credits, and more.
Providing actionable information to support strategic decision-making.
Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.
Offering a range of investment management and fiduciary services.
Bringing together companies and investors for tomorrow’s new deals.
Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.
Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.
Creating positive impact in our communities through increasing equity, access, and opportunity.
Dr. Teresa Ptashka is a patent agent with more than 10 years of experience in patent prosecution of early stage innovations in biology. She works with clients to obtain protection for their inventions and to provide intellectual property that is highly valued by investors.
I specialize in obtaining meaningful protection for early stage innovations in the U.S. and around the world. I work with clients and inventors to obtain protection for their technologies while also listening and taking into account where they think it will evolve in the coming years.
My technical experience spans the following areas: the microbiome, CRISPR/Cas genome editing, stem cells, tissue-specific progenitor cells, tissue engineering, drug treatments, repurposed drugs and modulation of cellular signaling or metabolic pathways.
The patent eligibility of natural products continues to be an issue, however newer U.S. PTO guidelines and recent patent allowances provide further insight into successful prosecution strategies for obtaining protection around natural products and their uses.
U.S. Patent and Trademark Office
University of Alberta, Edmonton, B.Sc., Pharmacology
University of Alberta, Edmonton, Ph.D., Pharmacology
Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe